Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Radioactive iodine (I
) is a common definitive treatment for Graves' Disease. Potential complications include worsening, or new development of Graves' eye disease and development of a radiation thyroiditis. The purpose of the present study was to assess outcomes of patients treated with I
in an Australian tertiary centre over 10 years.
Dat...
Alternative Titles
Full title
Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_07b1f0fed3824ce092793affb70f3c54
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07b1f0fed3824ce092793affb70f3c54
Other Identifiers
ISSN
1472-6823
E-ISSN
1472-6823
DOI
10.1186/s12902-018-0322-7